ChronoScale Closes $153M Placement and $220M JV Note; Files Macquarie Term Loan and STN Warrant
CHRN has more than doubled off its 52-week low of $3.5 on elevated volume (4.0× avg).
Summary
ChronoScale's Amendment No. 2 confirms closing of its $153 million common placement (~19.1 million shares) and the OD1 joint-venture contribution, and files the $220 million convertible note, the 850,000-share STN warrant, and Macquarie's $74.7 million term loan.
Key Events · Financing and Capital Events · CHRN
-
Placement Closes at $8.00
Company issued approximately 19.1 million common shares to the Common Stock Purchasers for aggregate gross proceeds of $153.0 million, closing the previously announced purchase agreement.
-
JV Contribution and $220M Note
The Contribution Closing occurred: OD1 JV Holdings issued a $220,000,000 convertible promissory note to CHRN OD1 Holdings, bearing 8% PIK interest and converting at $100.00 per Common Unit on HSR clearance.
-
Macquarie $74.7M Term Loan
The JV entered a Term Loan Agreement with Macquarie Equipment Capital for a $74,687,500 initial term loan at a 10% rate, used to repay STN's existing Macquarie obligations.
-
STN Warrant Terms
Company issued STN a warrant for up to 850,000 shares at a $0.001 exercise price, vesting on milestones, exercisable from May 18, 2027, with a 4.99% ownership blocker and a 19.99% warrant-shares cap.
Analysis · CHRN · Technology
This Amendment No. 2 confirms that the deals announced earlier today actually closed: roughly 19.1 million shares were issued for $153.0 million gross, the $220 million convertible note went into the OD1 JV, and Macquarie's $74.7 million term loan was signed. It also puts hard terms on paper that were previously only described — an 850,000-share warrant to STN at a $0.001 strike, a 4.99% ownership blocker, and a $220 million note that converts into JV common units at $100 per unit. The placement priced at $8.00 against a $9.57 market price, so existing holders absorbed dilution below the current quote; the offset is that the cash and the JV structure are now funded rather than pending.
How filings like this one have moved
In the 30 days to Nov 17, 2026, 48.3% of the 2133 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was -0.28%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, CHRN was trading at $9.57 on NASDAQ in the Technology sector, with a market capitalization of approximately $1.4B. The 52-week trading range was $3.50 to $30.00. This filing was assessed with neutral market sentiment and an importance score of 8 out of 10.